Bio-Rad Laboratories BIO Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.59B+1.9% | $2.58B+0.7% | $2.56B-0.9% | $2.55B-0.3% | $2.54B-2.5% | ||
| $1.25B+5.4% | $1.24B+4.7% | $1.22B+3.7% | $1.21B+2.2% | $1.18B-2.7% | ||
| $1.34B-1.2% | $1.34B-2.8% | $1.34B-4.7% | $1.35B-2.4% | $1.36B-2.3% | ||
| 51.9%-1.6pp | 51.9%-1.9pp | 52.3%-2.1pp | 52.8%-1.1pp | 53.5%+0.1pp | ||
| $265M-12.5% | $275.6M-6.9% | $284.9M+1.7% | $304.6M+30.9% | $303M+26.9% | ||
| $847.9M+5.0% | $844.3M+3.7% | $827.3M+1.2% | $820.9M+0.4% | $807.9M-2.8% | ||
| —— | —— | $224.4M-26.6% | $223.6M-32.7% | $248M-22.6% | ||
| $49.3M+1.4% | $49M+0.2% | $49.1M+0.2% | $48.9M-0.9% | $48.6M-1.5% | ||
| $77.3M-16.8% | $90.3M0.0% | $81.3M-9.5% | $90.9M-1.6% | $92.9M+2.5% | ||
| $222.3M+108% | $995.5M+142% | -$842.6M— | $450.1M— | -$2.75B— | ||
| $53.5M+109% | $235.6M+147% | -$166.7M— | $130.9M— | -$586.1M— | ||
| $5.81+108% | $27.65+143% | -$24.31+11.1% | $11.73+125% | -$76.20-636% | ||
| $1.12B+351% | $1.11B+312% | $224.4M-26.6% | $223.6M-32.7% | $248M-22.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Rad Laboratories's revenue?
- Bio-Rad Laboratories (BIO) generated $2.6B in revenue over the trailing twelve months, up 1.9% year over year.
- Is Bio-Rad Laboratories profitable?
- Bio-Rad Laboratories reported $168.8M in net income over the trailing twelve months, a 6.5% net margin.
- What are Bio-Rad Laboratories's profit margins?
- Gross margin is 51.9% and operating margin is 8.8%, with a 6.5% net margin.
- What is Bio-Rad Laboratories's earnings per share?
- Bio-Rad Laboratories's diluted EPS over the trailing twelve months is $5.81.
- Where does Bio-Rad Laboratories's income statement data come from?
- Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
